Real-time enrollment status for this lymphoma, non-hodgkin clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 4:59 PM UTC
| NCT Number | NCT07519772 |
| Recruiting Status | Recruiting |
| Condition | Lymphoma, Non-Hodgkin |
| Phase | PHASE1 |
| Target Enrollment | 280 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | August 14, 2026 (2 weeks ago) |
As of August 28, 2026: Clinical trial NCT07519772 is currently recruiting participants. This phase1 study for lymphoma, non-hodgkin is actively seeking new participants at 2 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07519772 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07519772 was last updated 2 weeks ago (August 14, 2026). HelloStudys verifies this status automatically.